168 related articles for article (PubMed ID: 37712971)
1. Nrf2 knockout attenuates the astragaloside IV therapeutic effect on kidney fibrosis from liver cancer by regulating pSmad3C/3L pathways.
Wang Q; Xu J; Li M; Chen Y; Xu Y; Li L; Gong Y; Yang Y
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1687-1700. PubMed ID: 37712971
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways.
Zhang C; Li L; Hou S; Shi Z; Xu W; Wang Q; He Y; Gong Y; Fang Z; Yang Y
J Ethnopharmacol; 2021 Oct; 279():114350. PubMed ID: 34157326
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV suppresses migration and invasion of TGF-β
Li L; Wang Q; He Y; Sun L; Yang Y; Pang X
Naunyn Schmiedebergs Arch Pharmacol; 2022 Apr; 395(4):397-405. PubMed ID: 35092472
[TBL] [Abstract][Full Text] [Related]
4. Amelioratory effects of astragaloside IV on hepatocarcinogenesis via Nrf2-mediated pSmad3C/3L transformation.
Fang Gong Y; Hou S; Xu JC; Chen Y; Zhu LL; Xu YY; Chen YQ; Li MM; Li LL; Yang JJ; Yang Y
Phytomedicine; 2023 Aug; 117():154903. PubMed ID: 37301185
[TBL] [Abstract][Full Text] [Related]
5. Smad3 C-terminal phosphorylation site mutation attenuates the hepatoprotective effect of salvianolic acid B against hepatocarcinogenesis.
Gong Y; Li D; Li L; Yang J; Ding H; Zhang C; Wen G; Wu C; Fang Z; Hou S; Yang Y
Food Chem Toxicol; 2021 Jan; 147():111912. PubMed ID: 33290806
[TBL] [Abstract][Full Text] [Related]
6. Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling.
Oh CJ; Kim JY; Choi YK; Kim HJ; Jeong JY; Bae KH; Park KG; Lee IK
PLoS One; 2012; 7(10):e45870. PubMed ID: 23056222
[TBL] [Abstract][Full Text] [Related]
7. Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocellular carcinoma progression via miR-145/miR-21 mediated Smad3 phosphorylation.
Wu C; Chen W; Fang M; Boye A; Tao X; Xu Y; Hou S; Yang Y
J Ethnopharmacol; 2019 Mar; 231():98-112. PubMed ID: 30412748
[TBL] [Abstract][Full Text] [Related]
8. Dihydroquercetin protects against renal fibrosis by activating the Nrf2 pathway.
Wang W; Ma BL; Xu CG; Zhou XJ
Phytomedicine; 2020 Apr; 69():153185. PubMed ID: 32120244
[TBL] [Abstract][Full Text] [Related]
9. Renoprotective mechanisms of Astragaloside IV in cisplatin-induced acute kidney injury.
Yan W; Xu Y; Yuan Y; Tian L; Wang Q; Xie Y; Shao X; Zhang M; Ni Z; Mou S
Free Radic Res; 2017; 51(7-8):669-683. PubMed ID: 28750561
[TBL] [Abstract][Full Text] [Related]
10. Chalcone flavokawain A attenuates TGF-β1-induced fibrotic pathology via inhibition of ROS/Smad3 signaling pathways and induction of Nrf2/ARE-mediated antioxidant genes in vascular smooth muscle cells.
Hseu YC; Yang TY; Li ML; Rajendran P; Mathew DC; Tsai CH; Lin RW; Lee CC; Yang HL
J Cell Mol Med; 2019 Feb; 23(2):775-788. PubMed ID: 30549180
[TBL] [Abstract][Full Text] [Related]
11. Astragaloside IV from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4/NF-кB in vivo and in vitro.
Zhou X; Sun X; Gong X; Yang Y; Chen C; Shan G; Yao Q
Int Immunopharmacol; 2017 Jan; 42():18-24. PubMed ID: 27855303
[TBL] [Abstract][Full Text] [Related]
12. Astragaloside IV Synergizes with Ferulic Acid to Alleviate Hepatic Fibrosis in Bile Duct-Ligated Cirrhotic Rats.
Zhao XM; Zhang J; Liang YN; Niu YC
Dig Dis Sci; 2020 Oct; 65(10):2925-2936. PubMed ID: 31900718
[TBL] [Abstract][Full Text] [Related]
13. Compound Astragalus and Salvia miltiorrhiza extracts modulate MAPK-regulated TGF-β/Smad signaling in hepatocellular carcinoma by multi-target mechanism.
Boye A; Wu C; Jiang Y; Wang J; Wu J; Yang X; Yang Y
J Ethnopharmacol; 2015 Jul; 169():219-28. PubMed ID: 25934513
[TBL] [Abstract][Full Text] [Related]
14. Hesperidin protects against chemically induced hepatocarcinogenesis via modulation of Nrf2/ARE/HO-1, PPARγ and TGF-β1/Smad3 signaling, and amelioration of oxidative stress and inflammation.
Mahmoud AM; Mohammed HM; Khadrawy SM; Galaly SR
Chem Biol Interact; 2017 Nov; 277():146-158. PubMed ID: 28935427
[TBL] [Abstract][Full Text] [Related]
15. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK
Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771
[TBL] [Abstract][Full Text] [Related]
16. Effect of astragaloside IV on indoxyl sulfate-induced kidney injury in mice via attenuation of oxidative stress.
Ji C; Luo Y; Zou C; Huang L; Tian R; Lu Z
BMC Pharmacol Toxicol; 2018 Sep; 19(1):53. PubMed ID: 30176914
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
[TBL] [Abstract][Full Text] [Related]
18. Activation of Nrf2/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-β1/Smad3 pathway: a promising therapeutic strategy for hepatic fibrosis - A review.
Gong Y; Yang Y
Life Sci; 2020 Sep; 256():117909. PubMed ID: 32512009
[TBL] [Abstract][Full Text] [Related]
19. A network pharmacology-based study on the mechanism of astragaloside IV alleviating renal fibrosis through the AKT1/GSK-3β pathway.
Yu X; Xiao Q; Yu X; Cheng Y; Lin H; Xiang Z
J Ethnopharmacol; 2022 Oct; 297():115535. PubMed ID: 35840059
[TBL] [Abstract][Full Text] [Related]
20. Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells.
Li Q; Liu G; Yuan H; Wang J; Guo Y; Chen T; Zhai R; Shao D; Ni W; Tai G
Oncotarget; 2015 Feb; 6(6):4253-65. PubMed ID: 25714018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
